Chronos DX

Giving people more time.

Chronos DX operates in healthcare based in London United Kingdom, founded in 2022.

Profile

ChronosDx is building a new bioassay platform technology for drug assays on in vitro cell models and non-invasive diagnostics on body fluids. Our platform enables highly sensitive, precision quantification of a wide range of biomarkers: proteins, metabolites, microRNAs, cell-free DNA and exosomes. We’re combining low-cost fabrication and scalable production with our unique insights, developed over 4 years of research, on single-molecule detection and dynamic concentration ranges in a multi-omic platform, with capability for in-line and in vivo continuous monitoring of biomarkers. Our first target market is in vitro cell-based assays for cancer drug development and liquid biopsy for early cancer detection, with the technology having unique advantages for these high value areas.

As a business in healthcare, Chronos DX is listed here with the public details available about it.

The company is recorded as being based in London United Kingdom.

The company is listed at the SOSV portfolio company stage of development.

Recorded headcount: 2-10 employees.

Website: chronosdx.co.uk